Safety and Effectiveness of COVID-19 Vaccines: Results from a Cross-Sectional Survey among Staff, Workers and Students at an Egyptian University.
Safety and Effectiveness of COVID-19 Vaccines: Results from a Cross-Sectional Survey among Staff, Workers and Students at an Egyptian University.
复制标题
DOI:
10.3390/vaccines10060846
复制
发表时间:
2022-05-26
期刊:
影响因子:
7.8
通讯作者:
Elmazar, Mohamed M.
中科院分区:
文献类型:
--
作者:
Hamza, Marwa S.;Tikamdas, Rajiv;El Baghdady, Noha S.;Sayed, Moustafa;Elbarazi, Amani S.;Badary, Osama A.;Elmazar, Mohamed M.
Mass vaccination is the most effective strategy against the spread of the COVID-19 pandemic. However, concerns about the vaccine’s safety and effectiveness remain a huge obstacle to vaccine acceptance. The aim of the present study was to explore different COVID-19 vaccine outcomes, including the development of adverse events and/or COVID-19 infection following COVID-19 vaccination. A cross-sectional study was conducted by distributing an online survey targeting staff and students at the British university in Egypt. A total of 637 participants fully completed the survey. Of these, 609 (95.6%) participants received the COVID-19 vaccine. Only 12.6% of the total vaccinated participants reported COVID-19 infection after vaccination. Of these, only 2.8% reported having severe symptoms while 9.9% reported having no or mild symptoms. The most common side effects reported after the first vs. second dose were headache (36.3% vs. 14.6%), tiredness and fatigue (26.9% vs. 10.7), and fever (25.6% vs. 6.7%). In conclusion, the present study explored different COVID-19 vaccine outcomes where the overall incidence of side effects is higher after the first dose than after the second dose. There is a relationship between COVID-19 vaccines’ side effects and gastrointestinal disorders, gender, and the type of COVID-19 vaccine. Post-vaccination symptoms were more frequently reported in women compared to men and more frequent with viral vector vaccines compared to other types. The effectiveness of different types of COVID-19 vaccines was confirmed by the lower incidence rate of post-vaccination COVID-19 infection.
登录
查看更多内容
影响因子:
3.8
作者:
Pandey K;Thurman M;Johnson SD;Acharya A;Johnston M;Klug EA;Olwenyi OA;Rajaiah R;Byrareddy SN
通讯作者:
Byrareddy SN
DOI:
10.1016/s1045-1870(03)00035-9
发表时间:
2003-07-01
期刊:
Seminars in pediatric infectious diseases
影响因子:
--
作者:
Gust, D A;Woodruff, R;Hibbs, B
通讯作者:
Hibbs, B
影响因子:
6.6
作者:
Loewe, Bernd;Wahl, Inka;Braehler, Elmar
通讯作者:
Braehler, Elmar
影响因子:
4.5
作者:
Bae S;Lee YW;Lim SY;Lee JH;Lim JS;Lee S;Park S;Kim SK;Lim YJ;Kim EO;Jung J;Kwon HS;Kim TB;Kim SH
通讯作者:
Kim SH
DOI:
10.1515/med-2022-0452
发表时间:
2022
期刊:
Open medicine (Warsaw, Poland)
影响因子:
--
作者:
Laganà AS;Veronesi G;Ghezzi F;Ferrario MM;Cromi A;Bizzarri M;Garzon S;Cosentino M
通讯作者:
Cosentino M